Intervention

Paliperidone ER

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 35 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials35
Recruiting0
Common conditions12
Lead sponsors shown15
Advertisement

Clinical trials

35 shown
A Pharmacokinetic Study of Paliperidone ERNCT02433717 · 2015-04-01
UNKNOWN
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute AgitationNCT01050478 · 2010-03-01
COMPLETED
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsNCT00934635 · 2009-09-01
TERMINATED
Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ERNCT02075528 · 2009-07-01
COMPLETED
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 YearsNCT01362439 · 2009-01-01
COMPLETED
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With SchizophreniaNCT00827840 · 2008-11-01
COMPLETED
Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)NCT01577186 · 2008-07-01
COMPLETED
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaNCT01541371 · 2008-07-01
COMPLETED
A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaNCT01577160 · 2008-05-01
COMPLETED
INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With SchizophreniaNCT00697658 · 2008-03-01
COMPLETED
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaNCT00757705 · 2008-03-01
COMPLETED
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With SchizophreniaNCT01724359 · 2008-02-01
COMPLETED
A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With SchizophreniaNCT01606228 · 2007-12-01
COMPLETED
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneNCT00535132 · 2007-10-01
COMPLETED
An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With SchizophreniaNCT00524043 · 2007-09-01
COMPLETED
A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent PatientsNCT00518323 · 2007-08-01
COMPLETED
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.NCT00488319 · 2007-06-01
COMPLETED
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With SchizophreniaNCT01662648 · 2007-06-01
COMPLETED
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaNCT00460512 · 2007-04-25
COMPLETED
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With SchizophreniaNCT00488891 · 2007-04-01
TERMINATED
A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and VacavilleNCT00790777 · 2007-03-01
COMPLETED
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IRNCT00791193 · 2007-03-01
COMPLETED
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.NCT00412373 · 2006-12-01
COMPLETED
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.NCT00397033 · 2006-11-01
COMPLETED
A Study of the Dose Proportionality of Extended Release PaliperidoneNCT00791167 · 2006-06-01
COMPLETED
A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderNCT00309686 · 2006-04-01
COMPLETED
A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderNCT00309699 · 2006-04-01
COMPLETED
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ERNCT00791713 · 2006-03-01
COMPLETED
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineNCT00791622 · 2006-01-01
COMPLETED
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaNCT00083668 · 2004-04-01
COMPLETED
A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.NCT00086320 · 2004-03-01
COMPLETED
Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaNCT00078039 · 2004-03-01
COMPLETED
Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With SchizophreniaNCT00077714 · 2004-01-01
COMPLETED
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release FormulationsNCT00796185 · 2003-08-01
COMPLETED
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release FormulationsNCT00796471 · 2003-06-01
COMPLETED

Leading sponsors

Trial status mix

COMPLETED32
TERMINATED2
UNKNOWN1

Phase mix

PHASE314
PHASE412
PHASE17
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.